Synergetics USA Inc. (SURG) is gaining ground on FDA news. Shares are up $1.09, or 28 percent, to $4.94.
The company said it received 510(k) clearance from the U.S. Food and Drug Administration for VersaVIT, a novel vitrectomy system for the retinal surgery market.
"The entry of VersaVIT into the global vitrectomy market is a major milestone in Synergetics' strategy to enter into higher growth areas of retinal surgery," said David Hable, President and CEO.
The company is awaiting CE mark approval, which has been submitted and is currently under review.
Synergetics is a medical device company that makes innovative microsurgical devices for ophthalmic and neurosurgical applications.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.